drugset / Trial / NCT06776432
Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of this study is to evaluate the effectiveness of sivopixant, acetazolamide and SASS-001 in adults with sleep apnea with a central component.
Timeline
- Start
- 2025-04-02
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetazolamide | Small molecule | — | Oral |
| Comparator | S-600918 | Unknown | — | Oral |
| Comparator | SASS-001 | Unknown | — | Oral |